KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-cash Items (2016 - 2017)

Neogenomics (NEO) has disclosed Non-cash Items for 4 consecutive years, with $2.1 million as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Non-cash Items rose 86.53% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2017, up 86.53%, and an annual FY2017 reading of $2.1 million, up 86.53% over the prior year.
  • Non-cash Items was $2.1 million for Q4 2017 at Neogenomics, down from $2.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.2 million in Q3 2015 and bottomed at $900000.0 in Q1 2015.
  • Average Non-cash Items over 4 years is $2.0 million, with a median of $2.1 million recorded in 2017.
  • The sharpest move saw Non-cash Items skyrocketed 117.36% in 2015, then plummeted 56.77% in 2016.
  • Year by year, Non-cash Items stood at $1.2 million in 2014, then skyrocketed by 117.36% to $2.6 million in 2015, then plummeted by 56.77% to $1.1 million in 2016, then soared by 86.53% to $2.1 million in 2017.
  • Business Quant data shows Non-cash Items for NEO at $2.1 million in Q4 2017, $2.1 million in Q3 2017, and $1.1 million in Q4 2016.